ESR1 and breast carcinoma: Interestingly, some studies have shown that the cholesterol metabolite 27-hydroxycholesterol acts as a signaling molecule through ER and liver X receptor (LXR) in ER+ breast cancer cells, which may explain how hypercholesteremia increases the risk in ER+ breast cancer cells [2,11,15].